Kastrati et al. found that DMF had anti-cancer stem cell properties by effectively blocking NFκB activity in multiple breast cancer cell lines and abrogating NFκB-dependent mammosphere formation (Kastrati et al., 2016). The gene discussed is NFKB1; the disease is breast carcinoma.